Cidara Therapeutics, Inc.
CDTX
株式のランク
#3185
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
株価
$221.38
最終同期: 2026-01-08
時価総額
$5.61B
変化（1日）
0.00%
変化（1年）
118.07%
国
US
取引 Cidara Therapeutics, Inc. (CDTX)
カテゴリー
Healthcare
Cidara Therapeutics, Inc.（CDTX）のP/B比率
October 2026 時点のP/B比率 TTM: 8.15
Cidara Therapeutics, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 8.15 です。2023 年末時点でのP/B比率は -8.46 でした。
Cidara Therapeutics, Inc. の P/B 比率の履歴（2012 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 8.15 | 676.07% |
| 2024 | 1.05 | -112.36% |
| 2023 | -8.46 | -53.54% |
| 2022 | -18.20 | -689.60% |
| 2021 | 3.09 | -60.21% |
| 2020 | 7.76 | 155.31% |
| 2019 | 3.04 | 195.54% |
| 2018 | 1.03 | -48.39% |
| 2017 | 1.99 | 16.56% |
| 2016 | 1.71 | -24.85% |
| 2015 | 2.27 | 265.81% |
| 2014 | 0.62 | -116.78% |
| 2013 | -3.70 | -95.75% |
| 2012 | -87.22 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 6.251 | -23.29% |
US
|
|
| 13.2547 | 62.66% |
US
|
|
| 4.208 | -48.36% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -24.13% |
NL
|
